MariMed
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
10.23.4
Price/Sales ratio
N/AN/A
Earnings per Share (EPS)
$0.01$0.03

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.44-3.94-61.47-67.18-45.95-1.9358.5239.088.93-6.2210.08-45.95
Price/Sales ratio
36.093.773.4213.2252.752.822.462.320.890.671.012.82
Price/Book Value ratio
-1.88-2.41-11.027.4010.0818.7314.467.452.041.392.3018.73
Price/Cash Flow ratio
-4.60-12.20-61.7662.82-215.01-5.3437.127.8716.4512.6218.57-215.01
Price/Free Cash Flow ratio
-2.91-1.39-3.43-4.06-52.84-3.77-80.3016.33-22.14-7.77-25.00-52.84
Price/Earnings Growth ratio
-0.000.040.68-0.39-0.07-0.00-0.570.220.110.020.1-0.07
Dividend Yield
N/A0.18%3.27%0.72%0.11%0.36%0.24%0.14%0.21%0.15%N/A0.36%
Profitability Indicator Ratios
Gross Profit Margin
-115.15%-2.64%62.07%57.88%65.90%41.00%61.54%54.55%47.72%44.36%47.72%41.00%
Operating Profit Margin
-924.76%-133.09%17.16%19.87%-45.19%12.28%28.55%22.11%15.19%10.14%18.71%-45.19%
Pretax Profit Margin
-8396.64%-145.40%9.01%-16.95%-112.29%-179.54%8.83%19.60%14.55%-4.43%14.55%-112.29%
Net Profit Margin
-8168.38%-95.68%-5.57%-19.67%-114.78%-145.85%4.21%5.94%10.05%-10.78%10.05%-114.78%
Effective Tax Rate
1.96%23.01%270.06%-65.74%26.94%18.76%45.97%67.98%30.21%-142.67%30.21%26.94%
Return on Assets
-436.93%-32.69%-2.32%-3.70%-16.39%-108.03%2.80%5.86%8.84%-8.17%8.84%-16.39%
Return On Equity
426.61%61.19%17.93%-11.02%-21.94%-966.59%24.70%19.08%22.89%-22.40%26.11%-21.94%
Return on Capital Employed
-671.00%-128.24%42.88%7.18%-7.32%22.55%27.30%27.98%16.20%9.12%19.95%-7.32%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.66N/A
Quick Ratio
0.710.370.380.321.570.160.611.280.930.840.650.16
Cash ratio
0.640.060.070.080.410.020.121.090.360.470.360.02
Days of Sales Outstanding
1.17K215.55198.05199.80350.6230.2366.5010.4220.5019.6120.5030.23
Days of Inventory outstanding
N/A10.70N/AN/A8.1716.54127.3964.58101.48111.71101.488.17
Operating Cycle
1.17K226.25198.05199.80358.7946.77193.9075.01121.98131.33106.53106.53
Days of Payables Outstanding
2.06K508.61127.49404.44353.6464.0294.0933.7134.5239.7334.5264.02
Cash Conversion Cycle
-887.55-282.3570.56-204.635.14-17.2599.8141.3087.4591.5911.005.14
Debt Ratios
Debt Ratio
1.240.960.650.500.180.580.490.150.200.350.620.18
Debt Equity Ratio
-1.21-1.81-5.021.500.245.274.360.490.530.971.610.24
Long-term Debt to Capitalization
5.732.572.270.330.150.650.740.310.300.470.340.15
Total Debt to Capitalization
5.732.221.240.600.190.840.810.330.340.490.370.19
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A14.81N/A
Cash Flow to Debt Ratio
-0.33-0.10-0.030.07-0.19-0.660.081.920.230.110.20-0.19
Company Equity Multiplier
-0.97-1.87-7.722.971.338.948.803.252.582.742.581.33
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-7.83-0.30-0.050.21-0.24-0.520.060.290.050.050.05-0.24
Free Cash Flow / Operating Cash Flow Ratio
1.588.7617.99-15.454.061.41-0.460.48-0.74-1.62-0.741.41
Cash Flow Coverage Ratio
-0.33-0.10-0.030.07-0.19-0.660.081.920.230.110.20-0.19
Short Term Coverage Ratio
N/A-1.10-0.050.11-0.71-1.030.2725.421.382.031.38-0.71
Dividend Payout Ratio
N/A-0.72%-201.06%-48.38%-5.07%-0.71%14.41%5.67%1.92%-0.98%N/A-5.07%